Dresden University of Technology-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2015

  1. Elotuzumab therapy for relapsed or refractory multiple myeloma

    New England Journal of Medicine, Vol. 373, Núm. 7, pp. 621-631

2007

  1. Chronic granulomatous disease (CGD) and complete myeloperoxidase deficiency both yield strongly reduced dihydrorhodamine 123 test signals but can be easily discerned in routine testing for CGD

    Clinical Chemistry, Vol. 53, Núm. 5, pp. 890-896